Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : biotechnology

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma
04/07/2025 | Companies
We're committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, Dr. Samuel Haile, Director of Cell Biology at Kite Pharma, shares insights...
biotechnology, cancer innovation, cancer research, cancer treatment, cell biology, cell therapy, immunology, innovative medicine, Kite Pharma, oncology, patient hope, Samuel Haile, The Centrifuge Sessions, virology

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey
04/03/2025 | Companies
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had been researching virology at Gilead for 12 years, and the first once-daily, single-tablet regimen for HIV...
antiviral therapy, biopharmaceuticals, biotechnology, breakthrough medicine, clinical trials, drug discovery, drug resistance, Gilead, global health, healthcare innovation, HIV, HIV prevention, HIV research, HIV treatment, medical innovation, medical science, pharmaceutical development, Tomas Cihlar, viral capsid, virology

Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement

Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement
01/01/2025 | Companies
Brii Biosciences Limited, a biotechnology company focused on developing treatments for diseases with significant unmet needs, announced its acquisition of intellectual property (IP) and other assets related to BRII-179 from VBI Vaccines, Inc., its subsidiaries, and creditors K2 VBI Equity Trust,...
biotechnology, Brii Biosciences, BRII-179, clinical trials, combination therapies, drug development, elebsiran, ENRICH study, functional cure, HBV, healthcare innovation, Hepatitis B Virus, intellectual property acquisition, know-how, patents, PEG-IFNα, Phase 2b study, shareholder value, unmet medical needs, VBI Vaccines


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com